EMEA-002238-PIP01-17

Key facts

Active substance
interferon beta-1a
Therapeutic area
Pneumology-allergology
Decision number
P/0305/2018
PIP number
EMEA-002238-PIP01-17
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of Acute Respiratory Distress Syndrome (ARDS)
Route(s) of administration
Intravenous use
Contact for public enquiries
Faron Pharmaceuticals Ltd

Tel.  +358 40 492762
E-mail: outi.jarvinen@faron.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating